CSTL

CSTL Operating Income Growth

-39.30%TTM

Period ending:

CSTL TTM Operating Income YoY %%
CSTL TTM Operating Income YoY %1411.13%-3766.47%
2019-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

CSTL operating income growth history

Year-over-year operating income growth rate. The available trailing twelve months (ttm) series contains 27 observations from Dec 31, 2019 to Jun 30, 2026.

Castle Biosciences Inc Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
-39.2972%
-141.4521%
-593.7716%
-3,265.4143%
-46.2842%
67.1159%
112.7543%
98.781%
83.7635%
58.1823%
27.1048%
0.5152%
-27.9122%
-66.2367%
-132.673%
-206.3422%
-278.8386%
-408.4387%
-512.6414%
-3,013.4458%
-369.44%
-236.5733%
-189.274%
-109.4634%
237.5728%
910.0673%
291.0501%

Compare operating income growth

All CSTL financial metrics · CSTL stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.